RecruitingNCT07565727

Cardiometabolic Disease and Substrate Metabolism

Cardiometabolic Disease, Substrate Metabolism, and Abnormal Placental Pathology: a Multimodal Maternal-Fetal Study

Sponsor

University of Tennessee Graduate School of Medicine

Enrollment

50 participants

Start Date

Dec 10, 2025

Study Type

OBSERVATIONAL

Conditions

Insulin Resistance Pregnancy Pregnancy Complications Preeclampsia Gestational Diabetes Gestational Diabetes Mellitus in Pregnancy Cardiometabolic Diseases Preeclampsia (PE)Gestational Diabetes Mellitus (GDM)Preeclampsia (PE) Risk Gestational Complications Placental Dysfunction

Summary

This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and maternal lipid oxidation.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cardiometabolic diseases, gestational complications, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

University of Tennessee Graduate School of Medicine

Knoxville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07565727

Related Trials

Better Lifestyle Counseling for African American Women During Pregnancy

NCT052341252 locations

Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation

NCT076614335 locations